1. Boston Scientific Corporation (NYSE:BSX)
Number of Hedge Fund Holdings: 102
Stock Upside: 41.66%
Boston Scientific Corporation (NYSE:BSX) is one of the best medical technology stocks to invest in. On February 6, RBC Capital lowered its price target on Boston Scientific Corporation (NYSE:BSX) to $115 from $130 and maintained an Outperform rating on the shares.
RBC made the move in response to Boston Scientific’s Q4 2025 earnings share on February 4. The firm attributed the price target cut to Boston Scientific’s initial 2026 guidance and perceived weakness in its electrophysiology business, which missed quarterly consensus expectations. RBC Capital indicated that investors appear to be in a “wait and watch” mode until all electrophysiology competitors report their results.
Boston Scientific’s stock now leans heavily on the upcoming CHAMPION‑AF trial results, due March 28, which analysts see as a key event that could boost earnings.
According to the earnings results, Boston Scientific’s quarterly revenue reached $5.29 billion. This is a 12.7% organic year over year growth, and slightly surpassed consensus estimates. Adjusted EPS were $0.80 and surpassed the $0.78 Wall Street expected.
Separately, on February 6, Bernstein SocGen lowered its price target on Boston Scientific to $112 from $130 and maintained an Outperform rating. Bernstein said it trimmed the price target because Boston Scientific missed US electrophysiology sales. The sales came in at $606 million for the fourth quarter, 6% below consensus estimates. The firm also noted a 2% miss in US Watchman sales for the quarter.
Bernstein stated that there is huge upside for Boston Scientific at a 21.5x valuation. The firm cited growth opportunities in electrophysiology through new launches, new data, and ambulatory surgery center expansion.
Boston Scientific Corporation (NYSE:BSX) develops and manufactures medical devices used in interventional medical specialties, including cardiology, endoscopy, urology, and neuromodulation. Its portfolio includes stents, catheters, implantable defibrillators, pacemakers, and devices for pain management and deep brain stimulation.
While we acknowledge the potential of Boston Scientific Corporation (NYSE:BSX) as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than BSX and that has 100x upside potential, check out our report about this cheapest AI stock.
READ NEXT: 12 Best Foreign Stocks to Buy Right Now and 11 Best AI Penny Stocks to Buy Right Now.
Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email below.
